First Time Loading...

Sight Sciences Inc
NASDAQ:SGHT

Watchlist Manager
Sight Sciences Inc Logo
Sight Sciences Inc
NASDAQ:SGHT
Watchlist
Price: 5.96 USD 6.24% Market Closed
Updated: May 6, 2024

Sight Sciences Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sight Sciences Inc
Revenue Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Sight Sciences Inc
NASDAQ:SGHT
Revenue
$81.1m
CAGR 3-Years
43%
CAGR 5-Years
61%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Revenue
$19.5B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Revenue
$14.7B
CAGR 3-Years
13%
CAGR 5-Years
8%
CAGR 10-Years
7%
Stryker Corp
NYSE:SYK
Revenue
$21B
CAGR 3-Years
13%
CAGR 5-Years
9%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Revenue
$40.3B
CAGR 3-Years
3%
CAGR 5-Years
6%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Revenue
$7.3B
CAGR 3-Years
17%
CAGR 5-Years
14%
CAGR 10-Years
13%

Sight Sciences Inc
Revenue Breakdown

Breakdown by Geography
Sight Sciences Inc

Not Available

Breakdown by Segments
Sight Sciences Inc

Total Revenue: 81.1m USD
100%
Surgical Glaucoma: 74.3m USD
91.7%
Dry Eye: 6.7m USD
8.3%

See Also

What is Sight Sciences Inc's Revenue?
Revenue
81.1m USD

Based on the financial report for Dec 31, 2023, Sight Sciences Inc's Revenue amounts to 81.1m USD.

What is Sight Sciences Inc's Revenue growth rate?
Revenue CAGR 5Y
61%

Over the last year, the Revenue growth was 14%. The average annual Revenue growth rates for Sight Sciences Inc have been 43% over the past three years , 61% over the past five years .